April 27, 2018 / 4:46 PM / a month ago

BRIEF-Eloxx Pharmaceuticals Announces Orphan-Drug Designation For ELX-02 For Treatment Of Cystinosis

April 27 (Reuters) - Eloxx Pharmaceuticals Inc:

* ELOXX PHARMACEUTICALS ANNOUNCES FDA GRANT OF ORPHAN-DRUG DESIGNATION FOR INVESTIGATIONAL DRUG ELX-02 FOR TREATMENT OF CYSTINOSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below